While biologic disease-modifying antirheumatic drugs (bDMARDs) have transformed outcomes of people with rheumatoid arthritis (RA), a proportion of patients are refractory to multiple bDMARDs.
Join TheConstructor to ask questions, answer questions, write articles, and connect with other people. When you join you get additional benefits.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results